Eosinophil‐derived neurotoxin and clinical outcomes with mepolizumab in severe eosinophilic asthma

Detalles Bibliográficos
Autores principales: Howarth, Peter, Quirce, Santiago, Papi, Alberto, Israel, Elliot, Mallett, Stephen, Bates, Stewart, Yancey, Steve, Albers*, Frank C., Kwon, Namhee
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Letters to the Editor
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592754/
https://www.ncbi.nlm.nih.gov/pubmed/32147844
http://dx.doi.org/10.1111/all.14266

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7592754/
https://www.ncbi.nlm.nih.gov/pubmed/32147844
http://dx.doi.org/10.1111/all.14266

Ejemplares similares